Top compounds associated with response to SCRT2


Feature Type Standardized
Nominal ANOVA
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.33 2e-09
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 8e-09
mRNA SU11274 CTRPv2 pan-cancer AAC 0.21 3e-08
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 3e-08
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 7e-08
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.2 2e-07
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.21 4e-07
mRNA PX-12 CTRPv2 pan-cancer AAC 0.17 7e-07
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-06
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 1e-06
Download CSV